Back
W.W. Grainger Vs. Biomarin Pharmaceutical Industry Stock Comparison
Buy
67
GWW
W.W. Grainger
Last Price:
1,013.63
Seasonality Move:
5.32%
Sell
33
BMRN
Biomarin Pharmaceutical
Last Price:
71.13
Seasonality Move:
5.7%
Buy
67
W.W. Grainger (GWW)
is a Buy
Is W.W. Grainger a Buy, Sell or Hold?
- The current W.W. Grainger [GWW] share price is $1,013.98. The Score for GWW is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
- GWW is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
33
Biomarin Pharmaceutical (BMRN)
is a Sell
Is Biomarin Pharmaceutical a Buy, Sell or Hold?
- The current Biomarin Pharmaceutical [BMRN] share price is $70.55. The Score for BMRN is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
- BMRN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GWW Stock Price Chart
What is W.W. Grainger's stock price today?
-
The W.W. Grainger share price today is $1,013.98
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GWW is experiencing slight selling pressure.
BMRN Stock Price Chart
What is Biomarin Pharmaceutical's stock price today?
-
The Biomarin Pharmaceutical share price today is $70.55
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing slight buying pressure.
GWW Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 11.35 | Buy |
Relative Strength Index (14 RSI): | 65.64 | Buy |
Chaikin Money Flow: | -82085 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (954.46 - 990.48) | Buy |
Bollinger Bands (100): | (913.73 - 972.65) | Buy |
BMRN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.98 | Sell |
Relative Strength Index (14 RSI): | 20.79 | Sell |
Chaikin Money Flow: | 1035913 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (81.58 - 93.32) | Sell |
Bollinger Bands (100): | (78.83 - 88.25) | Sell |
GWW Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 987.42 | Buy |
20-day SMA: | 975.72 | Buy |
50-day SMA: | 961.7 | Buy |
200-day SMA: | 929.55 | Buy |
8-day EMA: | 992.32 | Buy |
20-day EMA: | 978.5 | Buy |
50-day EMA: | 963.58 | Buy |
200-day EMA: | 911.43 | Buy |
BMRN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 80.97 | Sell |
20-day SMA: | 86.7 | Sell |
50-day SMA: | 86.17 | Sell |
200-day SMA: | 87.12 | Sell |
8-day EMA: | 79.59 | Sell |
20-day EMA: | 84.09 | Sell |
50-day EMA: | 85.42 | Sell |
200-day EMA: | 86.31 | Sell |
W.W. Grainger Earnings Growth & GWW Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.05 per share, an increase next quarter of $1.00 per share, an increase this year of $2.33 per share, and an increase next year of $3.50 per share.
Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.31 per share, an increase next quarter of $0.29 per share, an increase this year of $1.19 per share, and an increase next year of $1.04 per share.
W.W. Grainger Technical Analysis
Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Biomarin Pharmaceutical Technical Analysis
Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |